Cargando…

Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma

Detalles Bibliográficos
Autores principales: Demouche, Sarah, Juge, Pierre‐Antoine, Charles, Pierre, Descamps, Vincent, Benali, Khadija, Brunet‐Possenti, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786762/
https://www.ncbi.nlm.nih.gov/pubmed/36038806
http://dx.doi.org/10.1111/dth.15797
_version_ 1784858364113584128
author Demouche, Sarah
Juge, Pierre‐Antoine
Charles, Pierre
Descamps, Vincent
Benali, Khadija
Brunet‐Possenti, Florence
author_facet Demouche, Sarah
Juge, Pierre‐Antoine
Charles, Pierre
Descamps, Vincent
Benali, Khadija
Brunet‐Possenti, Florence
author_sort Demouche, Sarah
collection PubMed
description
format Online
Article
Text
id pubmed-9786762
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-97867622022-12-27 Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma Demouche, Sarah Juge, Pierre‐Antoine Charles, Pierre Descamps, Vincent Benali, Khadija Brunet‐Possenti, Florence Dermatol Ther Letters John Wiley & Sons, Inc. 2022-09-13 2022-11 /pmc/articles/PMC9786762/ /pubmed/36038806 http://dx.doi.org/10.1111/dth.15797 Text en © 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Letters
Demouche, Sarah
Juge, Pierre‐Antoine
Charles, Pierre
Descamps, Vincent
Benali, Khadija
Brunet‐Possenti, Florence
Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma
title Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma
title_full Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma
title_fullStr Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma
title_full_unstemmed Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma
title_short Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma
title_sort safe use of tocilizumab in rheumatic patients with kaposi's sarcoma
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786762/
https://www.ncbi.nlm.nih.gov/pubmed/36038806
http://dx.doi.org/10.1111/dth.15797
work_keys_str_mv AT demouchesarah safeuseoftocilizumabinrheumaticpatientswithkaposissarcoma
AT jugepierreantoine safeuseoftocilizumabinrheumaticpatientswithkaposissarcoma
AT charlespierre safeuseoftocilizumabinrheumaticpatientswithkaposissarcoma
AT descampsvincent safeuseoftocilizumabinrheumaticpatientswithkaposissarcoma
AT benalikhadija safeuseoftocilizumabinrheumaticpatientswithkaposissarcoma
AT brunetpossentiflorence safeuseoftocilizumabinrheumaticpatientswithkaposissarcoma